DERMATOP Healing Cream Plus is a healing cream with hyaluronic acid and silver sulfadiazine. It is intended for the treatment of skin wounds and lesions with a high risk of infection (burns, metabolic ulcers). Hyaluronic acid provides a moist environment for wounds, which is necessary for the natural healing process . Silver sulfadiazine has antibacterial and antifungal effects - this allows you to change the dressing only once a day, which contributes to the comfort of the patient, and also reduces the likelihood of wound contamination. DERMATOP Healing Cream Plus can be used on uninfected wounds to prevent infection and, after successful treatment of infected wounds, to prevent the recurrence of infection.
Main features:
- supports the healing of acute and chronic wounds
- has antibacterial and antifungal effects
- suitable for preventing infection
Composition
Main ingredient: Sodium hyaluronic acid 0.2%. Other ingredients: Silver sulfadiazine 1%, polyethylene glycol 400 monostearate, oleic acid decyl ester, emulsifying wax, glycerol, sorbitol solution 70%, purified water.
Use
Lesions should be cleaned before each application. Apply a thin layer of cream to the wound surface, 1-2 times a day , depending on severity, until complete healing occurs. Avoid direct contact of the tube with the wound. Prolonged treatment for one month should be assessed by a doctor. Cover the treated area with a sterile bandage. Do not expose the treated area to the sun.
Notice
Do not administer to children and pregnant women. Do not administer to patients with known individual hypersensitivity to the components of the product or to patients with hepatic or renal failure or glucose-6-phosphate dehydrogenase deficiency. Do not use concurrently with disinfectants containing quaternary ammonium salts or with locally applied proteolytic enzymes as they may interact with the product. Discard after 12 months of first opening. Keep out of reach of children.
READ THE INSTRUCTIONS FOR USE AND INFORMATION ON SAFE USE CAREFULLY. MEDICAL DEVICE class III, notification no. 0459.
